Press Releases
-
Quantify Research Opens New Office in Finland
Quantify Research has announced the opening of its new office today in Helsinki, Finland.
Feb 4, 2024
-
Showcase on lab automation instruments and consumables on display at SLAS2024 International Conference and Exhibition
Azenta Life Sciences has announced that it will display a range of productivity-enhancing consumables, instruments, and automated sample storage products at SLAS 2024 in Boston, USA from February 5 - 7.
Feb 4, 2024
-
Verisense Health Adopts Datavant’s Data Connectivity Platform to Expand its Digital Health Panel’s RWD Sources
Datavant’s privacy-preserving record linkage technology will allow Verisense Health’s digital health data to generate richer patient insights.
Feb 5, 2024
-
Bourne Partners Advises Clincierge on its Sale to Greenphire
Greenphire, a leading innovator in software solutions for streamlining clinical trials, proudly announces the acquisition of Clincierge, a premier provider of concierge travel and logistics support for patients participating in clinical trials. This strategic move is poised to revolutionize the landscape of clinical trial support services by integrating unparalleled patient care with cutting-edge technology.
Jan 31, 2024
-
Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies in the Space Streamline Clinical Trials
Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies in the Space Streamline Clinical Trials
Jan 31, 2024
-
Effortless Measurement of All Four NADs and Glutathione for Laboratories
NADMED has announced an innovative technology designed for effortless extracting and measuring all four NADs and two glutathiones.
Jan 31, 2024
-
Napp announces authorisation of REZZAYO® (rezafungin) in Great Britain by the UK Medicines and Healthcare Products Regulatory Agency for the treatment of invasive candidiasis in adults
-
Infinity Bio Launches Next-Generation Antibody Profiling Platform Utilizing MIPSA Technology
Infinity Bio, Inc. announces its new antibody profiling platform, leveraging Molecular Indexing of Proteins by Self-Assembly (MIPSA) technology. This platform offers unparalleled depth in immune system analysis, advancing immunology, virology, autoimmunity, and allergy research, providing new disease insights, and discovering new biomarkers and treatments. The MIPSA technology exploits recent advances in high throughput DNA sequencing and DNA synthesis, to create and analyze the most complete panels of immune targets available.
Jan 30, 2024
-
Creative Enzymes Revolutionizes the Field with Advanced Industrial Enzyme Production Service
-
Creative Enzymes Introduces Pyranose Oxidase from Microorganism for Enhanced Industrial Applicability
-
Creative Proteomics Bolsters Its Position in Biomarker Discovery with N-Glycan and O-Glycan Profiling Services
-
Creative Proteomics Offers Advanced Steroids Analysis Service for Medical Industry
-
Cresset Aims to Optimise Drug Discovery with Latest Drug Design Platform Release
Drug discovery specialists Cresset have just released a new version of their drug discovery platform Flare
Jan 28, 2024
-
CD BioSciences Releases Analysis of Marine Organisms to Drive Marine Bioresearch Forward
CD BioSciences announced the release of their comprehensive analysis of marine organisms aimed at propelling advancements in marine bioresearch.
Jan 28, 2024
-
Creative Proteomics Amplifies Its Services with High-precision Amino Acid Analysis
-
Alfa Chemistry Provides Customized Synthesis Services for Biotinylation Reagents
-
Alfa Chemistry Announces Ability to Supply Recombinant Human Collagens
-
CD Formulation Unveils Prominent Pharmaceutical Ingredients and Excipients for Enhanced Medicine Efficacy
-
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board
Robert S. Langer, Co-Founder of Moderna, Joins Lindus Health’s Advisory Board
Jan 24, 2024
-
Blue Spark Technologies Launches Innovative Multi-Vital Remote Patient Monitoring Platform – VitalTraq™
Blue Spark Technologies, Inc., a global leader in clinical-grade wearable and digital health tech, is launching a first-of-its-kind multi-sensor remote patient monitoring platform, VitalTraq™. VitalTraq includes one of the most groundbreaking contactless vital sign measurement sensors to date, Remote Photoplethysmography (rPPG). Using a simple 30 to 60-second selfie scan, patients, clinicians, and researchers can collect digital measurements, including Heart Rate, Heart Rate Variability, Blood Pressure, and Respiratory Rate vital signs in a single contactless patient experience.
Jan 24, 2024